ArticleJournal of functional biomaterials2025
Enhancing Radiopacity and Antibacterial Activity of Osteogenic Calcium Silicate Cement by Incorporating Strontium.
Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Influence of ZnO Addition on the Structural and Biological Properties of Borate Bioactive Glasses for Bone Tissue Regeneration.ACS omega · 2026Article
- Effect of Titanium Dioxide (TiOMaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Calcium silicate-based cement is commonly used for bone repair and regeneration. Current research focuses on developing innovative antibacterial materials with radiopacity, which is essential for ensuring successful clinical outcomes in procedures like vertebroplasty and endodontic treatments. Strontium (Sr) has emerged as a powerful additive, stimulating bone formation and inhibiting bone resorption. In this study, we evaluated the impact of varying levels of Sr-5, 10, and 20 mol% (designated as CSSr5, CSSr10, and CSSr20) on critical attributes of bone cement, including radiopacity, setting time, in vitro bioactivity, antibacterial efficacy, and osteogenic activity. The findings indicated that as the Sr content increased, the setting time and radiopacity of the cement increased. Remarkably, the cement formulations containing over 10 mol% Sr achieved radiopacity values surpassing the 3 mm aluminum threshold mandated by ISO 6876:2001 standards. Furthermore, incorporating Sr significantly improved MG63 cell attachment, proliferation, differentiation, and mineralization, while also boosting antibacterial properties in a dose-dependent manner. After 48 h of inoculation with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.